Join the Clinical Trial on Vitamin B1 for Alzheimer’s Disease at University of Iowa
Why Vitamin B1 Matters for Alzheimer's Disease
Vitamin B1, or thiamine, can be pivotal in addressing cognitive impairment. Research has shown potential correlations between thiamine levels and memory function, particularly in the context of Alzheimer’s disease. The University of Iowa is at the forefront of this inquiry.
Participate in the Clinical Trial
This groundbreaking clinical trial is now accepting participants in the early stages of Alzheimer’s disease. If you or someone you know is facing this challenge, consider joining this study to help advance our understanding of treatment options using benfotiamine.
Eligibility Criteria
- Must be diagnosed with early-stage Alzheimer’s disease
- Able to provide informed consent
- Willing to participate in the duration of the study
Contact Information
For more information about the study and how to enroll, contact University of Iowa Health Care.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.